Form 8-K - Current report:
SEC Accession No. 0001193125-24-221406
Filing Date
2024-09-18
Accepted
2024-09-18 16:21:31
Documents
22
Period of Report
2024-09-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d886256d8k.htm   iXBRL 8-K 40791
2 EX-99.1 d886256dex991.htm EX-99.1 11595
6 GRAPHIC g886256ex99_1s1g1.jpg GRAPHIC 37481
7 GRAPHIC g886256ex99_1s2g1.jpg GRAPHIC 134463
8 GRAPHIC g886256ex99_1s3g1.jpg GRAPHIC 106335
9 GRAPHIC g886256ex99_1s4g1.jpg GRAPHIC 85487
10 GRAPHIC g886256ex99_1s5g1.jpg GRAPHIC 64160
11 GRAPHIC g886256ex99_1s6g1.jpg GRAPHIC 65470
12 GRAPHIC g886256ex99_1s7g1.jpg GRAPHIC 24320
13 GRAPHIC g886256ex99_1s8g1.jpg GRAPHIC 66542
  Complete submission text file 0001193125-24-221406.txt   993750

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20240912.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20240912_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20240912_pre.xml EX-101.PRE 11721
25 EXTRACTED XBRL INSTANCE DOCUMENT d886256d8k_htm.xml XML 3793
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 241307829
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)